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INCIDENCE OF MYOCARDIAL
INFARCTION IN CORONARY ARTERIES
WITH PREVIOUSLY NON SIGNIFICANT
STENOSIS (<50%) IDENTIFIED ON ANGIOGRAPHY
ABSTRACT
The objective o f this study was to determine the frequency o f myocardial infarctions in
coronary arteries with previously non-significant (<50%) stenosis identified on coronary
angiography. The angiograms o f ten subjects who had undergone cardiac catheterization
prior to their acute myocardial infarction were evaluated. Six o f the ten subjects (60%)
were found to have an acute myocardial infarction in areas supplied by vessels with
<50% stenosis identified on previous angiography. Three o f these six subjects had
underwent percutaneous transluminal coronary angioplasty (PTCA) after angiography
and one subject undergone coronary artery bypass grafting (C ABG) prior to the initial
angiogram. Four o f the ten subjects (40%) included those who had >50% stenosis
identified on prior angiography in the infarct related artery. Although this study involved
a small sample that did not yield statistically significant results, the data did point to the
fact that an acute myocardial infarction can occur in vessels with non-significant (<50%)
stenosis.
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CHAPTER I
INTRODUCTION
Background to Problem
“No disease in the United States is responsible for more deaths, has stimulated
more research, and has engendered more controversy about how best to control it than
atherosclerosis (AS)."' Additionally, acute myocardial infarction (AMI), one
complication o f AS, is the single most common cause of death in industrialized nations
each year, and in the United States alone, results in roughly 500,000 fatalities o f the
estimated 1.5 million per year.' AS is characterized by the formation o f fibrofatty
plaques, or atheromas, which develop in the intimai layer o f blood vessel walls and can
protrude into the vessel lumen and result in a weakening of the underlying medial layer
o f the vessel. Although AS can affect any artery in the body, it most commonly occurs in
the aorta, coronary and cerebral vessels. Symptoms resulting from AS in the coronary
arteries can range from a mild, asymptomatic stage to a more severe, symptomatic stage
which includes dyspnea at rest or on exertion, chest pain, and diaphoresis. Complications
resulting from severe cases of AS in the coronary vasculature include ischemic heart
disease with congestive heart failure, angina pectoris, AMI and sudden death.'
Researchers have proposed several hypotheses regarding the pathogenesis of AS.
Currently, the Response-to-Injury Hypothesis is receiving the most attention in the
literature.'^ This hypothesis proposes that chronic or repeated injury to the endothelium
o f blood vessels results in some form o f nondenuding, subtle injury which initiates
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atherosclerotic changes. Once these injuring mechanisms are put into action, AS
begins to follow a well documented pattern o f development.^
Progression o f AS is classified in advancing stages I through VI. Stage V and VI
lesions are referred to as advanced or complicated and are responsible for producing
acute symptoms when they fissure or break open and their thrombogenic substances are
exposed.^ ® A detailed description o f development and progression o f AS in the coronary
arteries, otherwise known as coronary artery disease (CAD) is provided in the Literature
Review.
Currently, coronary angiography is the “gold” standard clinical tool for evaluating
patients with CAD ^ The objective o f coronary angiography is to examine the entire
epicardial coronary tree, recording details o f coronary anatomy that include the individual
pattern o f arterial distribution, anatomic or functional pathology, and the presence of
inter- and intracoronary collaterals.*"'“ Coronary angiography is used not only in the
diagnosis o f coronary artery disease, but also to assess the appropriateness and feasibility
o f various forms o f therapy aimed directly at the coronary arteries. Additionally,
information provided by coronary angiography is useful for assessing the results o f
therapy and in helping to formulate prognoses in patients with CAD '
Conventionally, the degree o f coronary artery obstruction is estimated as the
percent reduction o f the luminal diameter, determined by comparing the diameter at the
site of maximal reduction to that in adjacent areas that appear either normal or only
minimally diseased. A fundamental assumption in the evaluation o f “percent stenosis” is
that the angiographically “normal” segment o f the coronary artery adjacent to the lesion
is free o f atherosclerotic disease.^

A majority o f the current literature evaluating CAD distinguishes between
severity o f lesions by referring to them as “non-significant” or “significant” stenosis.
Non-significant stenoses are those which occlude <50% o f the arterial lumen and
significant stenoses occlude >50% o f the arterial lumen.*’ '* Although there is significant
interobserver variability using this conventional interpretation of coronary artery
obstructions, it remains clinically useful and is the most widely interpretation applied."
Studies have shown that significant stenosis o f >70% and total obstruction o f a
vessel are responsible for stable and unstable angina, as well as AMI.'"'* Generally,
when symptomatic obstruction is >70%, procedures such as coronary artery bypass
grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA) are
performed to reestablish blood flow to the myocardium. These have been successful in
the treatment o f stenosis and total obstruction o f the coronary arteries.
The procedures mentioned above, however, do not provide a means o f treatment
for those vessels which are <50% stenosed, or even <70% as a general rule. Stenoses
which commonly are referred to as “insignificant” are usually asymptomatic or mildly
symptomatic until they produce an AMI. S t u d i e s ' c o n d u c t e d previously indicate that
stenoses <50% are just as prone, if not more likely, to rupture and thrombose causing an
AMI than those stenoses >50%.
Problem Statement
A significant number o f AMI’s occur fi"om lesions which cause <50% occlusion;
however, mechanical interventions focus on treatment o f symptomatic lesions which
cause >70% occlusion.

Purpose
In an effort to support previous studies,

the purpose o f this study is to

determine if individuals with a history o f an AMI have evidence o f a non-significant
stenosis on a pre-AMI angiogram in the coronary vasculature supplying that myocardial
territory.
Significance o f the Problem
The effectiveness o f CABG and PTCA procedures have been demonstrated.
However, Little, et al.^ noted in their study that 57% o f AMI’s occurred in patients who
previously had PTCA, but the AMI had resulted from an untreated stenosis. Thirty-three
percent o f AMI’s occurred after CABG, but fi"om a stenosis in a non-bypassed artery. In
addition, two studies conducted by Kerensky, et al.^^^ noted similar results after PTCA.
In one study, 57% o f AMI’s occurring more than two weeks after successful PTCA were
due to an occlusion at a location other than the angioplasty site. In the second study, 64%
o f AMI’s after PTCA occurred at a location other than the angioplasty site.
This raises two issues. First, angiographical studies may not be able to predict
which stenosed artery will ultimately cause an AMI in many cases. Second, should
treatment be developed and directed toward insignificant lesions, in addition to the
significant lesions which currently are being targeted for treatment? In fact, wouldn’t
therapy directed at the whole coronary tree be ideal?
Hvpothesis
Myocardial infarction fi’equently occurs in coronary arteries with previously non
significant stenosis (<50%) identified on angiography.

CHAPTER 2
LITERATURE REVIEW
Introduction
Billions o f dollars are spent each year on the prevention, treatment, complications
and research o f atherosclerosis (AS). AS and its sequelae cause significant morbidity and
mortality in the United States and other westernized nations. Although we have
discovered a great deal about our nations number one killer in the last 20 years, we still
struggle to find effective prevention and treatment.
Atherosclerosis affects the intimai layer o f arteries, particularly medium and
larger-sized arteries. It is a progressive disease that begins in childhood and usually does
not produce symptoms until middle to late adulthood. Although AS can affect the entire
vascular system, it typically manifests itself as coronary artery disease (CAD), cerebral
vascular disease, aortic aneurysm and/or peripheral vascular disease, all o f which may
elicit dangerous symptoms or sudden death if left untreated. Since the focus o f this study
is on CAD and its sequelae, the remainder o f this literature review will focus on
atherosclerotic development in the coronary vasculature.
It is known that advanced areas o f AS in the coronary arteries can cause cardiac
tissue ischemia and death.

The purpose o f this study is to determine if individuals

with a history o f AMI have evidence of a non-significant stenosis on a pre-AMI
angiogram in the coronary vasculature supplying that myocardial territory. The
hypothesis o f this study proposes that myocardial infarction frequently occurs in arteries
with previously non-significant stenosis (<50%) identified on coronary angiography.
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In order to study the relationship between AS and AMI, several topics must be
considered. This literature review will include a brief review o f normal coronary
anatomy, descriptions o f the development and progression of AS, an overview of
diagnostic tests available to evaluate CAD and the current recommended medical and
surgical treatments for CAD. Additionally, current research examining arterial stenosis
and its relationship to AMI will be presented.
Arterial Anatomv
An artery is made up o f three major layers: the adventitia, media and intima. The
adventitia is the outermost layer and is made up o f dense collagenous tissue. This tissue
contains bundles o f collagen fibrils, elastic fibers, fibroblasts and a few smooth muscle
cells. Next to the adventitia lies the media. The media consists o f spiraling layers o f
smooth muscle cells forming a muscular tube. This tube allows for chemical and neural
regulation o f vessel diameter. The innermost layer o f an artery, the intima, is composed
primarily o f connective tissue, but also has smooth muscle cells scattered throughout. A
single layer o f endothelium separates the intimai layer fi'om the bloodstream.*
The coronary arterial vasculature begins as it branches off the aorta close to its
origin fi'om the left ventricle. The major vessels that are evaluated for CAD include the
left main trunk, left anterior descending, left circumflex and right coronary arteries. Due
to developmental variation, the inferior wall o f the left ventricle receives its blood supply
fi'om the posterior descending artery which may branch off from either the right coronary
artery or left coronary artery. This is referred to as right or left dominance, respectively.
Determining which system is dominant becomes an important factor when locating the
culprit lesion responsible for an inferior wall AMI.“

Development o f Atherosclerosis
The Response-to-Injury Hypothesis was first introduced in 1973.""* It has been
modified over the years because o f new research findings. However, its basic premise
still stands; injury to the endothelial layer lining the intima causes endothelial cell
dysfunction which initiates a sequence o f events leading to the development o f
atherosclerotic lesions. This theory proposes that injury may be initiated by any one of
the following: chronic hyperlipidemia, mechanical forces (ie. hypertension),
homocysteinemia, the immune system, bacteria or viruses.’
Whatever the mechanism o f injury may be, the proposed sequence o f events
remains the same. When endothelial cells are injured, there are an increased number of
adhesion molecules expressed on their surface. This results in an increased number of
low density lipoproteins (LDL) and monocytes migrating through the endothelium into
the intima. Once inside the intimai layer, monocytes are converted to macrophages and
function as scavenger cells. As LDLs are internalized, they undergo a process o f low
level oxidation. These newly oxidized LDLs (OxLDL) are viewed as foreign by the
newly present macrophages. The macrophages take up the OxLDL in large quantities
and become so engorged with lipids that when they are viewed microscopically, they take
on the appearance o f foam. Researchers refer to these as foam cells when they reach this
state.'®
As macrophages bind OxLDL, they become activated and secrete substances such
as growth factors and toxic substances. Damaged endothelial cells also release growth
factors. Growth factors stimulate the movement o f smooth muscle cells into the intima
fi'om the media as well as growth o f connective tissue. Toxic metabolic products
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released by activated macrophages damage the endothelium and contribute to further
propagate the response to injury cycle. Once the injuring mechanisms are put into action,
AS begins to follow a well documented pattern o f development.^
Progression o f Atherosclerosis
The Response-to-Injury Hypothesis was formulated to explain the initiating
mechanisms o f AS. The progression of AS, however, has been divided into six stages.
The earliest manifestation o f atherosclerosis is the appearance o f a fatty lesion or
“streak.” These streaks can be found in infants and young children and are composed of
foam cells and lipids within the intima. They appear grossly as yellow discolorations on
the walls o f arteries and are considered prearthromatous lesions. These intimai lesions
usually do not contain smooth muscle cells and the overlying endothelium remains
intact.*
Stages I and II o f AS classify the progression o f fatty streaks as they accumulate
large amounts o f lipids and macrophages in the subendothelium. As lesions advance to
stage m , extracellular lipids begin to pool within the intima. However, at this stage, a
single lipid core is not evident and necrotic cell debris and cholesterol crystals are
absent.* Diffuse intimai thickening is characteristic o f type IV lesions. This thickening,
according to the Response-to-Injury Hypothesis, is the result o f growth factors released
by macrophages and endothelial cells causing connective tissue hyperplasia. These
fibrous plaques may begin in the third decade o f life and progress with age. Located
within a fibrous plaque is a central core o f extracellular lipids and necrotic cellular debris.
This arthromatous substance is covered by a fibromuscular cap composed o f connective
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tissue, macrophages and smooth muscle cells. At this point, the plaque is much thicker
than the normal intima and bulges into the arterial lumen. ^
Type V and VI lesions are referred to as advanced or complicated lesions. They
are calcified fibrotic plaques undergoing various degrees o f ulceration, thrombosis and
necrosis. These plaques can also vary in their contents. Some advanced lesions contain
little lipid and are rigid and sclerotic; others are rich in lipid contents and have only a thin
fibrous cap. Advanced or “complex” lesions produce symptoms when they fissure or
break open and their thrombogenic substances are exposed.
Plaque Rupture
Plaque rupture fi'equently occurs in advanced atherosclerotic lesions. When a
plaque ruptures, its thrombogenic contents are exposed resulting in platelet adherence and
stimulation o f the coagulation pathway. The thrombus formed may be incorporated into
the plaque itself, further contributing to its enlargement, or can partially or completely
obstruct the arterial lumen, thus blocking distal blood flow. When the blood supply is
impaired or reduced to distal tissues, cell ischemia and/or death occur if the blood supply
is not quickly restored. If this occurs in a major vessel o f the coronary tree, the portion o f
the myocardium that it supplies will become ischemic and may die. However, the body’s
own fibrinolytic processes may be successful ai restoring blood flow or the thrombus
may occlude only a small portion of the arterial lumen still allowing some blood flow to
the myocardium.^*
Recent studies propose that plaque disruption is responsible for as many as 75%
o f thrombi which cause unstable angina, AMI and sudden cardiac death.^'^’^'^ The
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following paragraphs outline the current data about plaques which are prone to rupture
and the factors which may “trigger” such disruption.
In an article reviewing recent data regarding plaque disruption, Kirstensen, et al.^
state “the risk o f plaque disruption depends more on plaque type (composition) than on
plaque size and stenosis severity.” This review lists three known factors that determine a
plaques’ vulnerability to rupture; core size, cap thickness and cap inflammation and
repair. In his review o f the pathogenesis o f coronary syndromes, Shah^ also cited these
same three factors as determinants o f plaque disruption.
Plaques which have a large core o f lipids are at greater risk for rupture.^** In a
study done by Uchida, et al.^ which examined plaques by angioscopy, it was discovered
that glistening yellow plaques, those with a large lipid core, were associated with acute
coronary syndromes more frequently than white plaques, those with predominantly
fibrous content. Secondly, plaques with a thin fibrous cap have been shown to be at
greater risk for rupture because o f their susceptibility to mechanical forces, such as shear
stress and turbulent blood flow."’ Finally, those plaques with increased inflammatory
activity appear to be more prone to rupture. This is most likely due to the progressive
internal damage within the plaque by proteolytic enzymes. These enzymes are released
by activated macrophages within the plaque which weaken the cap, predisposing it to
rupture."
Falk® suggests that stability, vulnerability and the presence o f certain triggers
contribute to plaque rupture. Stability refers to the amount o f lipid-rich material that is
contained in the plaque. Vulnerability refers to the thickness o f the fibrous cap. He
describes triggers as specific stressors applied to the plaque, such as fluctuations in blood
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pressure, shear stress or cap tension. Additionally, Falk states that according to
Laplace’s Law, blood pressure and luminal diameter are positively correlated with tensile
stress. Therefore, those plaques which take up only a small amount o f the arterial lumen
diameter may be subjected to greater stress than more occlusive ones. While vasospasm
seems to be a logical cause o f plaque disruption, Falk cites the results o f several studies
disproving this hypothesis.
Another suspected trigger of plaque rupture is sympathetic nervous system
activity.®'^' The circadian rhythm is a documented pattern o f sympathetic activity which
leads to variations in heart rate, blood pressure and coronary blood flow throughout the
day. Muller, et al.^' state that clinical evidence shows peak times for AMI correlate with
surges in sympathetic activity occurring in the morning hours and that beta blockers have
been shown to blunt this response. Falk* states that sympathetic variation alone may not
be responsible for the high number o f morning AMI’s since fibrinolytic activity is low
and platelet aggregation and blood viscosity are both increased in the morning. All o f
these factors may contribute to a favorable setting for plaque rupture and clot formation.
Svmptoms o f Atherosclerosis
Atherosclerosis in the coronary vasculature is the most common cause of
ischemic heart disease. Ischemia occurs when there is an imbalance between the
myocardial oxygen demand and blood supply. Depending on the rate o f progression o f
AS and the myocardial response, different clinical syndromes may develop. These
include various forms o f angina pectoris, acute myocardial infarction, sudden cardiac
death or ischemic heart disease with congestive heart failure.' For the purposes o f this
study, the first three require further explanation.
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Angina pectoris is a general term used to describe symptoms, typically as
substemal chest pain caused by reversible myocardial ischemia. Angina pectoris can be
broken down further into stable angina, unstable angina and Prinzmetal’s angina. More
than one form may be present in the same patient.'
Stable angina pectoris, also known as typical angina, refers to episodic chest pain
associated with exertion or other forms of stress. It is often associated with a fixed
degree o f atherosclerotic narrowing in one or more o f the coronary arteries, which under
normal, resting conditions doesn’t produce symptoms. However, with exercise or other
conditions stressing the heart, the myocardial oxygen demand may not be met, thus
producing the classic crushing substemal chest pain patients often describe.'
Unstable angina pectoris is characterized by an increased fi*equency of chest pain.
These episodes, when compared to typical angina, are precipitated by progressively less
exertion on the heart as well as an increase in intensity and duration o f the attack.
Unstable angina may be a more severe clinical sign indicating that more serious,
potentially irreversible, myocardial ischemia may result. For this reason, this form of
angina is also sometimes referred to as preinfarction angina. It usually is “induced by
acute plaque change with superimposed partial thrombosis, distal embolization o f the
thrombus, and/or vasospasm.”'
A third form o f angina, Prinzmetal’s or variant angina, can occur. This type of
angina occurs at rest and can even awaken a patient from sleep. Symptoms in this
situation are associated with coronary artery spasm near an atherosclerotic plaque.'
Progression o f angina can lead to an AMI which may also occur in the absence o f
previous clinical symptoms. The majority of AMI’s occur as a result o f coronary artery
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thrombosis which in turn produce a defined area o f myocardial necrosis caused by
local ischemia.® The location o f an AMI is determined by the site o f occlusion within the
coronary vasculature. The size o f the infarct depends on if the occlusion was in a
proximal or distal segment o f that artery. Occlusion o f more proximal segments
generally produce larger infarcts involving the full thickness o f the myocardium.'
The final syndrome o f coronary AS is sudden cardiac death. This is usually due
to a large area o f necrosis in the myocardium. Patients may have had years o f angina
prior to their acute event or death may have been their first symptom o f AS. Among
these fatal cases, 50% die before they ever reach the hospital.'
Current Therapv for Coronarv Arterv Disease
Risk factor reduction
Risk factor reduction continues to be the first-line management for atherosclerotic
CAD. “...A risk factor is the trait that predicts the risk o f development o f clinically
significant disease within a population.”^ The risk factors for CAD include those which
are constitutional, or unchangeable. These include age, gender and family history. Risk
factors which are, to some point, modifiable include hyperlipidemia, hypertension,
cigarette smoking and diabetes mellitus.' Diet modification, weight loss, exercise and
smoking cessation are all components o f risk factor modification. If these measures fail
to diminish or reverse the progression o f CAD, pharmacotherapy may be initiated.
Pharmacotherapy
Several classes o f medications are involved in the treatment of CAD. The drugs
which have been shown to have some impact include aspirin, beta blockers, lipid
lowering drugs, nitrates and calcium channel blockers.
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Aspirin therapy is important in those patients with known CAD. Aspirin
irreversibly inhibits thromboxane A^ dependent platelet aggregation. It has been shown
to reduce the incidence o f AMI in persons with unstable angina.^
Beta blockers have been shown to blunt the sympathetic surges associated with
the circadian rhythm.^' These medications decrease the myocardial oxygen demand by
decreasing heart rate, myocardial contractility and systemic blood pressure.^
Drugs used to decrease serum lipid levels include fibric acid derivatives, nicotinic
acid, bile acid binding resins, HmG CoA reductase inhibitors, probucol and estrogen.
Each of these has its own unique mechanism o f action. Those drugs which lower LDL
while increasing high-density lipoproteins (HDL) are preferred. If monotherapy fails to
bring down the level o f serum lipids, a combination o f lipid lowering agents may be used.
Nitrates dilate the venous system which decreases the blood return to the heart.
This in turn reduces the workload o f the myocardium.'
Calcium channel blockers produce peripheral arterial vasodilation and coronary
arterial dilation. This allows an increased oxygen supply to the myocardium and a
decreased cardiac workload.'
Surgical intervention
Coronary angiography is used to evaluate the patency o f the coronary circulation.
Percutaneous transluminal coronary angioplasty (PTCA) is directed at flow-limiting
lesions in order to relieve angina or ischemia. A catheter with a small deflated balloon is
inserted into a peripheral artery and threaded into the coronary circulation to the desired
location. A sequence o f rapid inflation and deflation is used to diminish the obstruction
o f the targeted atherosclerotic plaque. It is currently indicated for AMI, stable or unstable
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angina, and objective signs o f ischemia evidenced on stress imaging studies.
Contraindications for PTCA include rapidly terminal disease o f cardiac or other causes.^
PTCA has become a common procedure and without complications, requires a less than
48 hour hospital stay. PTCA is not without its disadvantages, however. The balloon
procedure may need to be repeated several different times or rarely during the procedure,
the patient may require emergency bypass surgery.^
Surgical revascularization or coronary artery bypass grafting (CABG) has been
used to treat ischemic heart disease for many years. In order to be a candidate for CABG,
there must be clinical evidence o f ischemia, as well as an evaluation o f the coronary
circulation by angiography. The location o f suspected occlusions is important when
considering the type o f revascularization technique. A patients’ own saphenous vein or
internal mammary artery may be used to bypass the lesion in the coronary artery. One or
several grafts may be done at the same time depending on the extent o f the patients’
disease. This surgery is not without its’ risks either. Among several complications are
post-operative bleeding, intraoperative or postoperative AMI and cerebral vascular
accident (CVA). Despite the potential grave complications, several people benefit
greatly from this surgery and are able to live better, more productive lives.^
Diagnostic Tests Used to Evaluate Coronarv Artery Disease
There are a number o f screening tests, diagnostic tests and procedures that can be
done to evaluate CAD. However, each has its advantages, disadvantages and limitations
to the usefulness of the information it provides. This portion o f the literature review will
focus on the more common tests currently used for the evaluation o f CAD. These include
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electrocardiography, stress echocardiography, myocardial perfusion imaging and
angiography.
Electrocardiography
The electrocardiogram (ECG) is the most widely used diagnostic tool in the
evaluation o f chest pain.'”’^ It is a graphic recording o f the electrical activity o f the heart.
Electrocardiography is used as a screening tool, as a guide to therapeutic intervention and
as a definitive diagnostic tool. The ECG is noninvasive, painless, relatively inexpensive,
requires minimal patient cooperation and can be done quickly in a variety o f settings.*
In fact, it is the most common screening test for the detection o f CAD.* However, direct
visualization o f the coronary vasculature cannot be accomplished with this technique. If
abnormalities are observed on the ECG, further diagnostic studies are undergone to
assess the severity o f CAD.
The ECG may detect cardiac arrhythmias, conduction disturbances, myocardial
ischemia, or increased susceptibility to sudden cardiac death.* Therefore, it is used
primarily to diagnose and treat diseases o f the heart, but it is also used to detect certain
pulmonary and extracardiac events, such as life-threatening metabolic disturbances.^Stress echocardiography
A functional diagnostic test useful in identifying the extent and location o f CAD
is stress echocardiography.'” '^ Additionally, it can be used for pre-operative clearance
and to determine a need for further cardiac testing.'” Stress echocardiography can be
accomplished by using either a treadmill in patients who can tolerate physical activity or
by using dobutamine or dipryridamole in patients who can’t.
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The stress echocardiogram using a treadmill is done in combination with
standard two-dimensional (2-D) echocardiography. A baseline ECG, blood pressure and
2-D echocardiogram are obtained prior to exercise. The patient then proceeds to stress
the heart to peak stress by running or walking on a treadmill. Once exercise is stopped, a
second 2-D echocardiogram is obtained. Once heart rate and blood pressure return to
baseline, a post-stress 2-D echocardiogram is obtained. Comparisons are then made
between the echocardiograms to determine the extent and location o f CAD °
Patients requiring evaluation o f known or suspected CAD but are unable to
perform an adequate exercise test are candidates for a stress echocardiogram using
dobutamine to stress the heart.'^ Dobutamine causes a relative ischemia by increasing
heart rate and myocardial wall tension, therefore increasing myocardial oxygen
d e m a n d . P a t i e n t s receive a stepwise infusion o f dobutamine (5-lOpg/kg/min) until a
peak dose is reached (30-40|ig/kg/min). An ECG, 2-D echocardiogram and blood
pressure are done at every dose increase. Infusion is terminated if the patient experiences
angina, severe arrhythmias or a 1mm ST segment depression appears on ECG.'°
Some o f the advantages o f “pharmacological” stress over exercise include the
elimination o f respiratory artifact often present with physical exercise, immediate results,
availability at patient bedside, and the ability to assess both global and regional
myocardial function.'” '^ '* The extent o f stress-induced wall motion abnormalities
correlate with the extent o f angiographic disease.'"*
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Despite its potential advantages regarding cost and time efficiency, stress
echocardiography has some significant limitations: up to 30% o f patients do not have
adequate acoustic windows and image interpretation is highly observer dependent.^
Myocardial perfusion imaging
Myocardial perfusion imaging is another diagnostic test used in the evaluation o f
CAD It is used to study the health and function o f the myocardium by indicating the
actual coronary blood supply to the heart muscle and myocardial viability from all
vessels, thus showing the true state o f health o f the myocardium. Common indications
for myocardial perfusion imaging include screening o f suspected CAD, evaluating heart
function in known CAD and less commonly, for evaluation o f any other disease causing
functional changes in the myocardium. It may also be useful in detecting an AMI, even
within the first 24 hours."
The most commonly used agent in myocardial perfusion imaging is thallium-201
(Ti-oi) 5 Y|2o.

^ radioactive isotope which chemically resembles potassium and its

biological properties. Approximately 88% o f Tl‘°‘ “offered” to healthy myocardial cells
is taken up by them. ° Two factors which influence the myocardial uptake of Tl*”*
include the viability o f the myocardial tissue and the magnitude o f regional myocardial
perfusion.^^
The procedure itself is n on inv asiv e ,perfo rm ed with relative ease and generally
well tolerated. Tl^°' is injected into the bloodstream and will be readily taken up by
healthy myocardial cells which have active transport across their cell membranes. Those
regions o f the myocardium which show homogenous distribution o f activity are
considered normal. Areas of ischemia due to restricted coronary artery flow have
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damaged cell functions and take up T1

more slowly and in smaller amounts. Tissue

which has been infarcted will not take up any Tl^* at all. "
Typically, an initial scan is done when the Tl” ‘ is injected. A repeat scan is
usually performed approximately three or four hours later because regions with restricted
blood flow may eventually “fill in” with T l^ \ since it has a half life o f 73 hours. This is
defined as redistribution.* '" If a Tl^‘ imaging scan reveals redistribution, patients may
then be categorized as having a low or high risk o f subsequent myocardial infarction
based on the presence and size of the redistribution. "
Thallium scans can be performed at rest, with exercise or both. It is standard
practice to perform a two-part test with both rest and exercise components. The resting
TI^' scan alone is less sensitive in detecting CAD in those patients with only activity- or
exercise-induced angina. However, in patients who have anginal symptoms at rest, a
resting Tl*"' scan is usually only needed. In addition, certain patients that would benefit
fi'om both the resting and exercise scans may not be able to tolerate physical activity
because o f certain medical conditions or age. In this situation, a vasodilator, such as
dipyridamole or adenosine, may be given just before Tf"' injection to induce maximal
dilation o f the coronary artery beds, which normally occurs during exercise. "
In a meta-analysis of 122 studies done by Kotler and Diamond,” they report
sensitivity ranges between 68% to 96% (average, 84%) and specificity ranges between
65% to 100% (average, 87%) for exercise Tl” ' imaging used for the diagnosis o f CAD.
Additionally, when compared to exercise electrocardiography, exercise Tl” ' scanning
increases the sensitivity for detection o f CAD fi'om 60% to 80% and increases the
specificity fi'om 80% to 90%.* However, felse positives have been reported in patients
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with cardiomyopathies, valvular disease, hypertension, left ventricular hypertrophy,
hypertrophic subaortic stenosis, diabetes mellitus and various other medical conditions. "
In addition to Tl^', technetium (To 99m) sestamibi can also be used in myocardial
perfusion imaging studies. Tc 99m sestamibi is a radioactive tracer used in nuclear
medicine scans and is similar to Tl^°' in rest, exercise and vasodilator drug scans because
it collects in healthy myocardial cells." This combination is more useful in evaluating
CAD than the former combination. Although the mechanism o f technetium Tc 99m
sestamibi is not well understood, it provides more detailed perfusion images and seems to
allow better visualization o f the right ventricle.'"
In conclusion, myocardial perfusion imaging provides a noninvasive and welltolerated assessment o f CAD. Use o f Tl^°* or technetium Tc 99m sestamibi improves
localization o f ischemia and provides prognostic information since the presence and
number o f redistributing defects correlate with the incidence o f future cardiac events.^
However, this type o f cardiac imaging, as indicated by the study mentioned above, may
be limited in some patients by various medical conditions, such as diabetes mellitus and
hypertension, resulting in false positive results.
Angiography
Coronary angiography is the standard clinical tool for evaluating patients with
CAD. ^ Additionally, for more than two decades, the coronary angiogram has been the
standard on which major clinical decisions have been based, as well as the standard to
compare the accuracy o f other tests used in the diagnosis of CAD.”
Angiographic assessment o f the coronary arteries can be performed for many
reasons. One o f the most common indications is to determine the degree o f CAD in
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patients with angina pectoris. Others include confirmation o f the presence o f variant
angina, assessment o f myocardial infarction complications, as well as further evaluation
o f positive cardiac stress tests. Angiography also serves as a guide for medical and/or
surgical management o f cardiac patients.* '”
Coronary angiography involves the placement o f a catheter under fluoroscopy
through the aorta into the left and right coronary arteries. Several injections o f
radioopaque contrast dye are given so that the anatomy and patency o f the coronary
arteries can be viewed. Individual coronary arteries and their branches are injected
separately and viewed from different angles so that the entire coronary artery circulation
may be visualized. A disadvantage o f this procedure is that it cannot be used to evaluate
the lumen in cross-section and does not provide and image o f the arterial wall unless
calcification is present.
Once coronary angiography has been performed, many clinical decisions are
based on the severity o f coronary artery obstruction. This is usually estimated visually in
terms of “percent stenosis.”’ A majority o f the current literature evaluating CAD
distinguishes between severity o f lesions by referring to them as “non-significant” or
“significant” stenosis. Non-significant stenoses are those which occlude <50% o f the
arterial lumen and significant stenoses occlude >50% o f the arterial l u m e n . H o w e v e r ,
a fundamental assumption in the evaluation o f “percent stenosis” is that the
angiographically “normal” segment of the coronary artery adjacent to the lesion is free of
atherosclerotic disease.’
Although coronary angiography is a widely used and accepted form o f CAD
evaluation, current research suggests some limitations on its use. In a postmortem study
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done by McPherson, et al., their results “...demonstrate that diffuse coronary
atherosclerosis is often present when coronary angiography reveals only discrete
stenosis,” suggesting that “coronary angiography may underestimate the severity and
extent o f coronary disease.” As a consequence, measurements o f “percent stenosis” often
do not correlate with the physiologic importance o f a lesion. Additionally, in a study
done by Little, et al.,‘* their findings suggest that “coronary angiography may
underestimate the extent o f coronary atherosclerosis and that an abnormality in
endothelial function that may help promote thrombus production can exist in coronary
arteries that do not contain an angiographically significant stenosis.” In yet another
study. Little^ concluded that “...lack o f apparent stenosis in an arterial segment does not
necessarily indicate that the segment is free from atherosclerosis, particularly if stenotic
lesions are present elsewhere in the coronary arteries.”
Based on the findings in the above-mentioned studies, it has not been determined
if coronary angiography can accurately predict the site o f a subsequent coronary artery
occlusion that will produce an AMI. Therefore, it is unlikely that therapy aimed only at
sites o f angiographic coronary obstruction will be effective in preventing future AMI’s.
Mvocardial Infarction and Arterial Stenosis
Plaque rupture and acute thrombosis are responsible for the majority of acute
coronary events.^'^'^'^" Determining which plaques have the potential to rupture and
thrombose is very important. It is known which factors make plaques vulnerable to
rupture.^'^ However, predicting which plaques co-existing in the same coronary artery
will rupture and which o f those that will not is a bit more challenging. Little is known
about preexisting arterial stenosis in an infarct related artery.^
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Coronary angiography is a tool used to evaluate the severity o f CAD
However, it is limited by its inability to provide information about the components of
plaques. Plaques are evaluated by the extent to which they occlude the arterial lumen
rather than their composition. Plaques defined as non-significant stenoses are those
which occlude <50% o f the arterial lumen and significant stenoses are those occluding
>50% o f the arterial lumen.’"

Several studies’"''*’'^ have attempted to correlate the future

site o f a subsequent AMI in those arteries which had significant stenosis identified on
prior angiography.
Little, et al.’* evaluated 29 patients with mild to moderate CAD who experienced
an AMI with coronary angiography done both before and after the event. The second
angiogram was used to determine which plaque was responsible for the AMI. Analysis
o f data revealed that in 19 patients (66%), the culprit lesion was <50% occlusive. In
addition, the culprit lesion was <70% occlusive in 28 patients (98%). They concluded
that AMI occurred in arteries containing the most severe stenosis on initial angiography.
In the majority (66%) o f these patients, though, the occlusion was originally <50% of the
arterial lumen.
Similar results are reported in a retrospective study done by Giroud, et al.,’^ where
92 patients who had coronary angiograms performed prior to and after an AMI The
arterial segment responsible for the subsequent AMI occluded the arterial lumen by
>50% on the initial angiogram in only 20 o f the 92 patients (22%). Upon examination o f
the second angiogram, it was discovered that 32% o f the AMI’s were the result o f
rupturing by the most severely stenosed artery. It was also found that the stenosis in the
culprit segment was o f a higher degree in the first arteriogram when the time between the
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first film and the AMI was shorter (p = 0.04). In conclusion, the authors reported that
the severity o f arterial narrowing was a poor predictor o f subsequent AMI.
Ambrose, et al.'^ performed a retrospective analysis o f two groups totaling 38
patients. Group I consisted o f 23 patients who had an AMI with coronary angiography
performed both before and after the event. Group II consisted o f 15 patients who had one
or more new total occlusions at the time o f the second study without suffering an AMI.
Thirty percent o f those patients who had an AMI had a normal appearing culprit coronary
segment on initial angiography. Eleven (48%) o f 23 lesions in Group I were responsible
for <50% occlusion and 5 (22%) o f 23 lesions were causing >70% stenosis. In Group

n,

6 (33%) o f 18 lesions were responsible for <50% occlusion and 11 (61%) o f 18 lesions
were causing >70% stenosis. They discovered that “these differences between Group I
and n in the percent stenosis on initial angiography o f the lesions were the site of
infarction or new total occlusion at restudy were clinically significant (p<0.05).” This
group o f researchers concluded that “...one cannot predict the location o f a subsequent
infarction from analysis o f a previous angiogram” and that “myocardial infarction
appears to develop frequently from a coronary lesion that was less than severe on prior
angiography.”
Patients with ischemic heart disease were studied by Nobuyoshi, et al.*° over a 13
year period. These 239 patients underwent serial angiography at least twice and had a
myocardial perfusion study done during the study period. Patients were divided into
three groups according to the progression o f their CAD between angiograms. Group I
consisted of 39 patients who had had an AMI. Group II consisted o f 90 patients who had
CAD progression in the absence o f AMI. Group HI consisted o f 110 patients who had no
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CAD progression. In 23 o f 39 (59%) patients in Group I, arterial segments which were
<50% occluded were responsible for the AMI. This study concluded the “...mild stenosis
was often the site o f acute occlusion leading to myocardial infarction.”
Hackett, et al.*' studied the angiograms o f 60 patients who presented with an AMI
and received successful intracoronary thrombolytic therapy. The authors examined the
severity o f the residual coronary stenoses. Patients underwent angiography before,
during and after therapy. The researchers found that “a residual stenosis o f less than 60%
was present in 28 (47%) o f patients and less than 50% in 12 (20%).” Although the
authors admitted that measuring residual stenosis immediately after thrombolysis is likely
to lead to overestimation o f stenosis severity, they do believe that at least 26% and
perhaps more o f the patients in their study “...have preexisting infarct-related coronary
stenoses o f less than 60% obstruction diameter.”
Ambrose,'* Little,'* Hackett,*' Nobuyoshi^" and Giroud'^ suggested in their studies
that non-significant stenoses (<50%) are responsible for a large number o f AMI’s than
previously thought. These studies also agreed that the location o f subsequent AMI
cannot be predicted by angiography. Ambrose, et al.'^ found that 30% of those in the
study who had an AMI had normal appearing arteries on previous angiography. This
raises the concern that there may be a portion o f the population with asymptomatic,
undetectable, atherosclerotic plaques at risk for AMI. Further studies are needed to
determine the significance that these data holds for the rest o f the population.
Conclusion
Atherosclerotic CAD is a major health problem in the United States. Its
development is insidious over many years. Its sequelae o f angina pectoris, myocardial
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infarction, and sudden cardiac death consume a large amount o f health care dollars and
are responsible for a great deal o f human suffering. Medicine has a responsibility to
develop adequate screening techniques and therapeutic interventions to treat this
significant problem. Additionally, according to the studies reviewed above, a large
portion o f those with from CAD are at risk for an AMI. Therefore, continual evaluation
o f the currently accepted diagnostic tools and treatment goals for CAD is warranted.

CHAPTERS
METHODOLOGY
Study Design
The design o f this study was a retrospective cohort design involving patients who
experienced an acute myocardial infarction (AMI) or had diagnostic coronary
angiography between January 1, 1995, and December 31, 1998.
Study Site and Subjects
The study was conducted at the offices o f Grand River Cardiology, PC., 1000
East Paris SE, Grand Rapids, MI, 49546. Subjects were identified from the medical
records at Grand River Cardiology, P C , based on a diagnosis code o f “acute myocardial
infarction” (410.0 - 410.9) using the 1998 International Classification o f Diseases, 9th
Revision, Clinical Modification, Fifth Edition (ICD-9-CM), or a procedure code o f “left
heart catheterization, retrograde, from the brachial artery, axillary artery or femoral
artery; percutaneous” (93510) using the 1998 Physician’s Current Procedural
Terminology. Either the acute myocardial infarction or the left heart catheterization must
have occurred between January 1, 1995, through December 31, 1998. The AMI may or
may not have been the subjects’ first documented AMI.
After the initial selection o f study subjects, additional inclusion criteria were met.
The first criterion required that the AMI must have been diagnosed based on at least two
out o f three o f the following: typical cardiac ischemic pain lasting >30 minutes,
persistent ST segment elevation typical o f AMI in >2 electrocardiogram (ECG) leads, or
elevation o f serum creatine kinase levels to three times the normal limit. These criteria
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are the current acceptable standards for noninvasive diagnosis o f an

The

second inclusion criterion stated that the subject had to have had a previous angiographic
assessment o f the coronary vasculature prior to the AMI. This provided a baseline degree
o f the patients’ existing coronary artery disease.
Once inclusion criteria were determined, one exclusion criterion was evaluated.
This criterion excluded subjects who had their angiographic study done at any institution
other than at Saint Mary’s Health Services, 200 Jefferson SE, Grand Rapids, MI, 49503.
Equipment and Instruments
Coronary angiography is the standard clinical tool to evaluate the coronary
vasculature for CAD.’-’’ Therefore, the equipment used for the procedure, which has
been approved by the Food and Drug Administration (FDA), is assumed to be accurate
and valid by the researchers. The equipment used for coronary angiography is located at
Saint Mary’s Health Services, 200 Jefferson SE, Grand Rapids, MI, 49503, in the
radiology department where coronary angiograms are performed.
A caliper was used during angiographic assessment to measure stenotic areas in
the left main trunk, left anterior descending, left circumflex and right coronary artery by
comparing them to the nearest adjacent normal arterial segment in that same artery. A
fundamental assumption in the evaluation o f “percent stenosis” is that the
angiographically “normal” segment o f the coronary artery adjacent to the lesion is free o f
atherosclerotic disease.’
Subjects’ medical records were located at the office o f Grand River Cardiology,
P C , where the data collection took place. Subjects were not directly involved in the
study; only medical record data were used. The researchers involved in this study have
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completed patient confidentiality meetings and have signed a “Confidentiality
Statement for Research Studies” form (see Appendix A).
The Subject Data Form (see Appendix B) was used as a guide when reviewing all
charts. Inclusion and exclusion criteria mentioned above were met with this form.
Subjects who met the study criteria were assigned a number in order to eliminate their
names from the Subject Data Form. However, a Subject Data Form Master List (see
Appendix C), which included each subjects’ assigned number, name and date of birth,
was kept so that angiograms could be found for each subject at Saint Mary’s Health
Services. Angiograms were then reviewed and significant data recorded on the
appropriate Subject Data Form.
Validitv/Reliabilitv
In order to eliminate concerns related to interrater reliability, Gregory L. Miller,
M.D., F. A.C.C., a physician at Grand River Cardiology, P C., interpreted all angiograms.
Procedure
Subjects o f this study were patients from the office o f Grand River Cardiology,
P C , in Grand Rapids, MI. Initially, all medical records were screened and a list was
compiled o f all patients who had either an AMI since January 1, 1995, based on a
diagnosis code o f acute myocardial infarction (410.0 - 410.9) using the 1998 International
Classification o f Diseases, 9th Revision, Clinical Modification, Fifth Edition (ICD-9CM) or a procedure code o f “left heart catheterization, retrograde, from the brachial
artery, axillary artery or femoral artery; percutaneous” (93510) using the 1998
Physician’s Current Procedural Terminology. From this list, the Subject Data Form was
used to review the medical records o f all potential subjects. The data were collected from
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medical records during the months starting December 1, 1998, through January, 1999,
by going through selected records and recording applicable data on the Subject Data
Form. This was done by the researchers Brandi Haik and Amy Schreur.
Once all data were collected. Dr. Miller reviewed the subjects’ coronary
angiograms at Saint Mary’s Health Services in Grand Rapids, MI. Dr. NÆller, without
prior knowledge o f the official angiography results or which vessel was responsible for
the AMI, used a caliper to measure, in millimeters, lumen diameter at the point of
maximal stenosis of an artery, as well as that arterial segment which appeared to be
normal. These data were then converted into a percentage to represent the degree o f
coronary arterial occlusion. This was done by dividing the narrowest portion of
occlusion by the nearest normal-appearing portion of that same artery, multiplying by one
hundred and rounding to the nearest fifth percentage. The four arteries evaluated
included the left main trunk, left anterior descending, left circumflex and the right
coronary artery. Additionally, the dominance, right or left, o f coronary arterial
circulation was determined by identifying which artery the posterior descending artery
originated from in patients who had an inferior AMI. This information was recorded on
the Subject Data Form in the Angiography section.
All Subject Data Forms were collected and kept in a manila envelope throughout
the study period. The Subject Data Form Master List was kept in a separate envelope and
stored at the office o f Grand River Cardiology, P C , during the study period, except
when reviewing angiograms at Saint Mary’s Health Services. After the conclusion o f the
study, the Subject Data Forms and Subject Data Form Master List are and will be kept in
the offices o f Grand River Cardiology, P C , for a period o f three years.

CHAPTER4
ANALYSIS OF DATA
Techniques o f Data Analysis
Ten subjects met the inclusion criteria o f this study; however, because ten is a
small sample, statistical analysis is difficult. Therefore, descriptive analysis will be used
to attempt to identify relationships between variables identified in this study for each o f
the ten subjects included.
Subject Characteristics
Three hundred and eighty-four subjects were selected based on the initial study
criteria. Following medical record review, 374 subjects were excluded for the following
reasons: 256 had not had a subsequent AMI; 112 had angiography after the AMI
occurred; 3 did not meet the two out three criteria for an AMI diagnosis; and 3 underwent
angiography at an institution other than Saint Mary’s Health Services.
With the remaining 10 subjects, various risk factors were evaluated and are
presented in Table 1 below. Additionally, the subjects were divided into two groups.
Group I consists o f six subjects (60%) who were found to have an AMI in vessels with
<50% occlusion identified on previous angiography. The four subjects (40%) in Group II
include those who had >50% occlusion identified on prior angiography in the infarct
related artery.
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Table 1
Subject Risk Factors
All Subjects

Group I (<50%)

Group n (>50%)

fn = 101

In = 6)

(n = 4)

67 (SD= 11.20)

63

73

Male
Female

7
3

4
2

3
1

Diabetes Mellitus

2

I

1

Family History of CAD

8

4

4

Hypertension

7

5

2

Tobacco Use

4

4

0

Mean Age (yr)
Sex

CAD = coronary arterv disease

It is interesting to note the incidence o f risk factors between Group I and Group U.
Two of the risk factors evaluated in this study, diabetes mellitus and positive family
history o f coronary artery disease (CAD), have an equal distribution between the two
groups. However, o f the seven subjects who have hypertension, five (71%) of them fell
into Group I. Additionally, all four subjects (100%) with a history o f tobacco abuse were
placed into Group I as well.
Indications for angiography varied for the subjects in this study. Four o f the
subjects (40%) had unstable angina, two o f the subjects (20%) had stable angina, and the
remaining subjects had various other indications. These included shortness of breath,
determination o f appropriate interventions and for diagnostic purposes.
In six o f our 10 subjects, the artery with the maximal amount o f occlusion
identified on angiography was responsible for three (50%) o f the subsequent AMI’s. In
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the other three subjects, the artery with the culprit lesion was not the artery identified
as having maximum stenosis in that subject on angiography. Furthermore, two o f the six
subjects (33%) had an AMI in a vessel with <50% occlusion identified on angiography.
These data are presented below in Table 2.
Table 2
Percentage o f Maximal Stenosis and Actual Percentage in
Culprit Arterv Responsible for AMI in Patients W ithout Surgical Intervention
Patient No.
3
4
5
6
8
9

Maximum stenosis
on aneioeram
100
60
90
0
100
100

Percent stenosis of
culorit lesion
85
10
90
0
100
100

Location of AMI
inferior
anteroseptai
inferior
anterior
inferior
inferolateral

As stated previously, six o f the subjects (60%) were found to have an AMI in
vessels with <50% occlusion previously identified on angiography. O f these six subjects,
four (66%) received surgical intervention as treatment for their CAD prior to the AMI.
Three o f these six subjects underwent percutaneous transluminal coronary angioplasty
(PTCA) after their initial angiogram. One subject underwent coronary artery bypass
grafting (C ABG) prior to their angiogram. Despite these surgical interventions, the
angioplastic and bypassed vessels were responsible for the subsequent AMI in each o f
these subjects. The actual percentage of occlusion due to the culprit lesion at the time o f
AMI in subjects receiving PTCA is unable to accurately be determined because post
intervention stenosis is not routinely identified. The subject with prior CABG had a
patent saphenous vein graft in the culprit artery on angiography. Therefore, for purposes

34
of this study, the culprit lesion is assumed to present with <50% occlusion at the time
o f infarction. These data are presented in Table 3 below.
Table 3
Percentage o f Maximal Stenosis and Actual Percentage in
Culprit Arterv Responsible for AMI in Patients With Surgical Intervention
Patient No.

Maximum stenosis
on aneioeram

I
2
7
10

80
95
95
80

Percent stenosis of
culorit lesion
?
?
<50%
?

Location of AMI
inferior
anterior
inferoposterior
inferoposterior

The time interval, in months, between the date o f angiography and the date the
subject presented with AMI was compared between Group I and Group II mentioned
above. The results are listed in Table 4 below
Table 4
Time in Months Between Angiography and AMI
All Subjects

Group I (<50%)

Group n (>50%)

In = 101

In = 61

In = 41

Subject Number
I
2
3
4
5
6
7

8
9
10
Mean
* = without sureical intervention

57
4
6
6
27
7
20
30
2
57
21.6

57
4
6

6*
27
7
20*
30
2
57
25.2

16.3
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The range for number o f months between angiography and subsequent AMI for
ail subjects was between 2 and 57 months with a mean o f 21.6 months. Those subjects in
Group I had a mean greater than the total number o f subjects. However, two (33%) of
the six subjects (subject numbers 4 & 6) who did not receive surgical intervention had a
mean o f 6.5 months. Additionally, these subjects had only had 10% and 0% stenosis on
angiography in the culprit artery. Subjects in Group U had a mean o f 16.3 months, lower
than that o f the total group.
Group I and Group II were again compared to determine whether there was a
difference between their medications at the time of the AMI. The medications identified
in this study are currently indicated for the treatment o f symptoms and to slow or reverse
the progression o f CAD. These include aspirin, beta blockers, HmG Co A reductase
inhibitors, nitrates and calcium channel blockers. Again, presented in Table 5, all
subjects were represented, as well as a breakdown o f medications taken by subjects in
both Group I and Group II.
Table 5
Medications at Time of AMI
All Subjects

Group I (<50%)

Group n (>50%)

in = 10)

fn = 6)

In = 4)

Aspirin

5

3

2

Beta Blockers

5

3

2

HmG CoA Reductase
Inhibitors

4

2

2

Nitrates

3

2

1

Calcium Channel Blockers

4

2

2

36
This study found that no greater than 50% o f subjects were on any one o f the
medications that have been indicated for the treatment o f symptoms and to slow or
reverse the progression o f CAD. Only 50% were on either aspirin or beta blockers, 40%
on a cholesterol-reducing medication, 30% on nitrates and 40% on calcium channel
blockers. Additionally, there was no identifiable relationship between Group I and II
with any o f the medications and incidence o f subsequent AMI.
The following table (Table 6) breaks down medications at the time o f AMI for
each subject, along with the number of months between the angiogram and AMI.
Table 6
Medications at Time of AMI vs. Months Between Aneiographv and AMI

Subject
Number;
I
2
3
4
5
6
7
8
9
10

ASA

BB

HmG CoA RI

Nitrates

CCB

Months

N
Y
Y
N
Y
Y
N
N
N
Y

N
Y
N
Y
Y
Y
N
Y
N
N

N
N
Y
Y
Y
N
Y
N
N
N

N
N
N
N
N
Y
Y
N
Y
N

N
N
N
Y
N
N
Y
Y
Y
N

57
4
6
6
27
7
20
30
2
57

ASA=asDirin: BB=beta blockers; CCB=calcium channel blockers

When reviewing Table 6, there isn’t any obvious correlation between the
medications at the time o f AMI and the amount o f time between angiography and AMI.
However, it is worth noting that two of the subjects (20%) had the identical scenario with
the exception o f one subject taking aspirin on a daily basis at the time o f AMI. Subject
number one had an 80% occlusion on angiography, underwent PTCA and was not taking

37
any medication at the time o f the AMI 57 months later. Similarly, subject number 10
had 80% occlusion on angiography, underwent PTCA but still infarcted fifty-seven
months later; however, this subject was taking aspirin.
Hvpothesis
Our hypothesis stated that myocardial infarction frequently occurs in coronary
arteries with previously non-significant stenosis (<50%) identified on angiography.
Although our study did not yield statistically significant data to uphold this hypothesis,
the data still point to the fact that an AMI can occur in vessels with such non-significant
lesions. Furthermore, it has been shown in the literature^ *'*that PTCA and CABG do not
necessarily prevent future AMI’s in the surgically treated vessel. The data presented
above in those subjects who had PTCA or CABG prior to their AMI support this
observation as well.

CHAPTERS
DISCUSSION
Interpretation o f Findings
Although the results o f this study were not statistically significant due to the small
sample, it did find that six out o f ten subjects (60%) had an acute myocardial infarction
(AMI) where the culprit lesion was <50% stenosed on prior angiography. These results
are consistent with prior studies by Ambrose, et al.,‘^ Little, et al.,‘* Nobuyoshi, et al.“
and Giroud, et al.‘®
Ambrose, et al.*^ found in their retrospective analysis o f 38 patients that 48% of
their sample had culprit lesions causing <50% stenosis. Thirty percent had normalappearing coronary arteries prior to AMI identified on angiography. Only five o f their
patients (22%) had culprit lesions causing >70% stenosis. Little, et al.‘* found that of
their 29 patients, 19 (66%) had culprit lesions causing <50% stenosis and 28 (98%) had
culprit lesions with <70% stenosis. Nobuyoshi, et al.“ identified 39 patients who
underwent angiography and subsequently had an AMI. O f these, 23 patients (59%) had
lesions responsible for the AMI previously identified as causing <50% occlusion in the
culprit artery. Giroud, et al.'® studied 92 patients with coronary angiography prior to and
after a subsequent AMI. They found that the arterial segment responsible for the AMI
occluded the arterial lumen by >50% in only 20 (22%) o f the 92 patients.
Despite having received either percutaneous transluminal coronary angioplasty
(PTCA) or coronary artery bypass grafting (CABG), four subjects (40%) in this study had
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progression of coronary artery disease (CAD) to AMI. This supports studies done by
Little, et al.^ and Kerensky, et

who concluded that PTCA and CABG did not

prevent future cardiac events in the surgically treated vessel.
Little, et al.

22

found 57% o f AMI’s occurred in patients who previously had

PTCA, but the AMI resulted in a vessel with an untreated lesion. Thirty-three percent o f
AMI’s occurred after CABG, but from a stenosis in a non-bypassed artery. In two
studies conducted by Kerensky, et al.,

23*24

the first noted 57% o f AMI’s occurring more

than two weeks after successful PTCA resulted from occlusions other than the
angioplasty site. Similarly, in a second study, 64% of patients had occlusions in an
untreated vessel.
The results o f this study identified four subjects with a history o f tobacco abuse.
All o f these subjects were found to have a non-significant lesion in the culprit artery
resulting in AMI Nicotine has been shown to induce arterial vasospasm^ and may have
been a triggering event in the evolution o f the AMI in these subjects.
Clinical Implications
The results o f this study point to the fact that lesions considered non-significant
(<50%) on prior angiography should also be addressed when determining CAD
management. Lesions which do not warrant surgical intervention should still be treated
medically to prevent a subsequent AMI.'*
Brown, et al.” suggest two goals for optimal management of CAD. First,

. to

diminish the symptomatic limitations imposed by arterial obstructive disease.” This is
accomplished by restoring the balance o f oxygen supply and demand to the myocardium
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via surgical intervention and plaque regression. In their article, studies are cited which
have linked reductions in low-density lipoprotein (LDL) by lifestyle alterations and lipidlowering medications to variable degrees o f plaque regression. Furthermore, Brown and
Fuster,^ state that “only about 12% o f all coronary lesions visibly regress (>10% stenosis
change) with intensive lipid lowering.” Although there is evidence that plaque regression
is possible,^^ additional studies are needed in order to provide sufficient data to establish
plaque regression as a valid goal and accepted standard for CAD therapy.
The second goal suggested by Brown, et al.” is “. ..to prevent the anticipated
worsening o f symptoms or progression to clinical events such as sudden death,
myocardial infarction or worsening angina... ” This goal can be achieved by plaque
stabilization. Shah^ also suggests similar goals in his study. Both researchers suggest
four ways to promote plaque stabilization. These include improving endothelial function;
ensuring favorable thrombotic-thrombolytic equilibrium; eliminating triggering
conditions or activities; and altering plaque composition.
Even though PTCA and CABG successfully restore oxygen supply and improve
quality o f l i f e , * o t h e r known lesions elsewhere in the coronary vasculature should not
be overlooked. This study revealed that despite surgical intervention, subjects still went
on to have an AMI. Therefore, it is important for clinicians to consider the fact that
regardless o f surgical intervention, these patients remain at risk for subsequent AMI.
When reviewing medications taken by subjects included in this study at the time
o f AMI, there was no correlation found between medications and length o f time between
angiography and AMI. Furthermore, the data did not reveal that one medication or
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combination o f medications was able to prevent subsequent AMI in either those
subjects with arteries having non-significant (<50%) or significant (>50%) coronary
stenoses.
Limitations of the Studv
The first, and probably most important, limitation o f this study was the size o f the
sample. With only ten subjects meeting inclusion criteria, it became difficult to conclude
any significant statistical correlation between variables.
Although not necessarily a limitation, but rather a reason for the small sample
size, the researchers conclude that the inclusion criteria may have been too strictly
defined. O f the 374 medical records reviewed, the selection criteria automatically
eliminated 112 subjects (30%) admitted with an AMI because o f the absence o f an
angiogram before infarction. This number is not surprising since many people who
present to emergency rooms with their first AMI do not have a previous history o f pre
infarction symptomology.^ Another 256 subjects (68%) had angiography, but did not
have a subsequent AMI at the time o f this study.
In addition to the strict inclusion criteria, another reason for the small sample in
this study involves evaluating subjects from only one cardiology practice. Not only did
this limit the number o f subjects who potentially could have been included in this study,
it may have impacted the number and characteristics o f subjects who did receive
angiography. Although there are solid indications for angiography,*•'“ some clinicians
may utilize angiography more frequently for diagnostic purposes rather than other less
invasive tests such as stress echocardiogram or myocardial perfusion imaging.
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Including only those subjects who had angiography performed at Saint Mary’s
Health Services also limited our sample size as well. Subjects who had their angiogram
done at another institution were excluded from this study. Although this did not exclude
a significant number o f subjects, it did eliminate three. Furthermore, if these subjects had
been included in our sample, they would not have made a considerable impact in our
sample size to allow for statistical rather than descriptive analysis.
The lack o f quantitative measurement, other than the use o f a caliper, to estimate
percent stenosis o f arteries on angiography may have affected results in this study.
However, subjective evaluation o f coronary morphology is reasonably reproducible, and
the estimated percentage o f the diameter o f a stenosed artery remains the best simple
clinical index to define the severity o f a coronary lesion.'®
Finally, coronary artery disease may have progressed significantly in those
arteries that appeared to be non-significant (<50%) on angiography prior to subsequent
AMI. Because o f the length o f time between angiography and AMI in some subjects, the
degree o f stenosis at the time o f AMI may have been underestimated due to variable
progression o f atherosclerosis.
Further Research
Based on the findings o f this study and others,'^'*'®’^' further research is warranted
to attempt to conclude statistically significant results. Ideally, a larger sample size o f at
least 100 subjects would yield higher accuracy and correlation o f results.
Additionally, further research could examine whether there is a significant
difference in the incidence o f AMI in those subjects treated medically, and those subjects
receiving either PTCA or CABG for treatment of symptomatic CAD.
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Further investigation may be done to determine if coronary plaque morphology
is related to the likelihood o f plaque disruption, thrombosis and vessel occlusion leading
to an AMI.
Finally, conducting a prospective study using the same variables, rather than
retrospective, may be o f greater benefit. This would enable the researchers to enroll
subjects at the time o f initial angiography, implement and monitor drug regimens more
effectively and identify modifiable risk factors.
Conclusion
Coronary artery disease and its sequelae has been shown to be an important cause
of morbidity and mortality in the United States.' Although the sample size o f this study
limited the ability to draw statistically significant conclusions from the data, valuable
observations have been made. Patients with prior history o f PTCA or CABG and those
with non-significant (<50%) stenosis on angiography should not be considered to lack
risk for AMI than those with significant (>50%) stenosis. This coincides with study
findings o f Ambrose,'* Little,'* Hackett,^' Nobuyoshi^ and Giroud'’ previously described.
Finally, risk factor reduction and pharmacological therapy aimed at the entire
coronary tree in an effort to reduce symptoms, slow progression and stabilize plaques
should be instituted in all patients identified with CAD to prevent future AMI.'*-^'*
Furthermore, studies are needed to be able to accurately identify patients with
asymptomatic CAD, and thus determine appropriate intervention in those patients to
prevent angina pectoris, acute myocardial infarction or sudden death.
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Confidentiality Statementfo r Research Studies

In carrying out its mission. Saint Mary’s Health Services (SMHS) endeavors to improve the quality of
patient care and the health status o f the community and to protect the confidentiality o f patients.
While Saint Mary’s seeks to achieve all o f these goals to the fullest degree possible, it recognizes that
at times these goals can be in conflict; improvement o f the quality o f care and o f health status require
access to data; but such access can place at risk patient confidentiality.
Sensitive to the SMHS mission and to the conflicts that can arise, I understand that information is
required for me to perform research. Some o f this information may concern patients being treated at
SMHS or it may concern the operations o f SMHS. I understand that any patient medical information
belongs to the patient and that I am only permitted to access patient medical information to the extent
that it is necessary to conduct my researclL I also understand that all medical and personal
information regarding patients is confidential and must not be revealed or discussed with other
patients, fnends, or relatives, or anyone else within or outside the SMHS healthcare envirorunent.
I also understand that other information regarding the operations o f SMHS is confidential. This
information concerns employees, financial operations, quality assiuance, utilization review, risk
management, research, procurement, contracting, credentialing o f staff and other provider
information. I understand that I am only authorized to access this information if it is required for me
to conduct my research. This information must not bè revealed or discussed with others within or
outside o f SMHS except to the extent that it is necessary to conduct my research.
I understand that I am required to protect any SMHS patient or operations information fi-om loss,
misuse, unauthorized access, or unauthorized modification.
I agree to abide by all policies and procedures of SMHS as it relates to patient confidentiality, medical
records, and research studies. No unauthorized copies o f data or records will be made or maintained.

I understand that failure to follow all policies regarding the confidentiality o f information is a cause
for termination o f contract with or revocation of access to SMHS and may subject me to potential
civil o r criminal liability.

tetOi^dL SkLÙc______________

I0|a3|98_______

Signature

Date

Manager, Clinical Information Services

Date

October 2.1998
K:\Research\Research PaekefMEDREC.lVPD
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Confuli*ntiality Statementfor Research Studies

In carrying out its mission. Saint Mary’s Health Services (SM H ^endeavors to improve the quality o f
patient care and the health status of the community and to proton the confidentiality of patients.
While Saint Mary’s seeks to achieve all of these goals to the fullest degree possible, it recognizes that
at times these goals can be in conflict; improvement of the quality o f care and of health status require
access to data; but such access can place at risk patient confidentiality.
Sensitive to the SMHS mission and to the conflicts that can arise, I understand that information is
required for me to perform research. Some o f this information may concern patients being treated at
SMHS or it may concern the operations of SMHS. I understand that any patient medical information
belongs to the patient and that I am only permitted to access patient medical information to the extent
that it is necessary to conduct my research. I also understand that all medical and personal
information regarding patients is confidential and must not be revealed or discussed with other
patients, fnends, or relatives, or anyone else within or outside the SMHS healthcare environment.
I also understand that other information regarding the operations o f SMHS is confidential. This
information concerns employees, financial operations, quality assurance, utilization review, risk
management, research, procurement, contracting, credentialing o f staff and other provider
information. I understand that I am only authorized to access this information if it is required for me
to conduct my research. This information must not be revealed or discussed with others within or
outside o f SMHS except to the extent that it is necessary to conduct my research.
I understand that I am required to protect any SMHS patient or operations information from loss,
misuse, unauthorized access, or unauthorized modification.
I agree to abide by all policies and procedures o f SMHS as it relates to patient confidentiality, medical
records, and research studies. No unauthorized copies o f data or records will be made or maintained.

I understand that failure to follow all policies regarding the confidentiality o f information is a cause
for termination o f contract with or revocation o f access to SMHS and may subject me to potential
civil or criminal liability.
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/o /x sh ? "

Signature

Date

Manager, Clinical Information Services

Date

October 2. I99S
fS. RetiHTchSlesearch PackecStFDRECMTD
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SUBJECT DATA FORM
SUBJECT INFORMATION
Date o f Birth (m/d/y)

Subject #____
Gender

1 Male
2 Female

if female,
HRT

Yes
( 1)
__
__
__
__

Diabetes mellitus
Family History o f CAD
Hypertension
Tobacco use

1 Yes
2 No

if yes, __ 1 Estrogen
2 Progesterone
3 Combination

No
(2)

ANGIOGRAPHY
Indication;

Date (m/d/y)

I angina, stable
2 angina, unstable
3 atypical chest pain
4 other____________

Results

% Occlusion

PTCA PTCA Date
( 1)

CABG CABG Date
( 1)

Left Main
LAD
Left Circumflex
RCA

MYOCARDIAL INFARCTION INFORMATION
Date (m/d/y)

/

/

Medications at time o f MI:

Location

Yes
( 1)

No
(2)

Aspirin
Beta blockers
Calcium channel blockers
Nitrates
“Statins”
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1 Anterior
2 Lateral
3 Inferior
4 Posterior
5 Anterolateral

6
7
8
9

Anteroseptal
Infero lateral
Inferoposterior
Posterolateral
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SUBJECT DATA FORM MASTER LIST
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No.
Subject No._
Subject No.
Subject No.
Subject No.
Subject No._
Subject No._
Subject No._
Subject No.
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No.
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._
Subject No._

Name
Name_
Name_
Name
Name
Name_
Name
Name_
Name
Name
Name
Name_
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name_
Name_
Name
Name
Name
Name
Name
Name
Name_
Name_
Name_
Name
Name
Name
Name_
Name
Name
Name

D .O.B.
D O.B.
D .0J3.
D .O.B.
D .O.B.
D O.B.
D .OB.
D OB.
D OB.
D OB.
D OB.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D O.B.
D OB
D OB
D OB
D O.B.
D O.B.
D. O.B.
D, O.B.
D. O.B.
D. O.B.
D. O.B.
D. OB.
D. OB
D. O.B.
D O.B.
D. O B
D. OB.
D. OB.
D. OB.
D OB.
D. O.B.
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